GLYCOPYRRONIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glycopyrronium, and when can generic versions of Glycopyrronium launch?
Glycopyrronium is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in GLYCOPYRRONIUM is glycopyrronium tosylate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the glycopyrronium tosylate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GLYCOPYRRONIUM?
- What are the global sales for GLYCOPYRRONIUM?
- What is Average Wholesale Price for GLYCOPYRRONIUM?
Summary for GLYCOPYRRONIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for GLYCOPYRRONIUM |
| DailyMed Link: | GLYCOPYRRONIUM at DailyMed |
US Patents and Regulatory Information for GLYCOPYRRONIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | GLYCOPYRRONIUM TOSYLATE | glycopyrronium tosylate | CLOTH;TOPICAL | 214448-001 | Apr 3, 2026 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
